Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Pharm Res. 2014 Jan 23;31(6):1605–1615. doi: 10.1007/s11095-013-1265-3

Figure 3.

Figure 3

In vitro drug release from the dual nanodrug CPVA-FLOX/17-AAG and CPVA-FLOX/PCL. (A) 17-AAG, and (B) PCL (C) FLOX release in simulated gastric fluid (pH 1.2). (D) FLOX release from CPVA-FLOX nanogel-drug conjugate at physiological condition (pH 7.4). Shown data are means ± SD (n = 3).